Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Skjøt Arkil, Helene ^a,b   Clausen, Rikke E ^a   Rasmussen, Lars M ^c   Wang, Wanchun ^d   Wang, Yaguo ^d   Zheng, Qinlong ^d   Mickley, Hans ^c   Saaby, Lotte ^c   Diederichsen, Axel C P ^c   Lambrechtsen, Jess ^e   Martinez, Fernando J ^f   Hogaboam, Cory M ^f   Han, MeiLan ^f   Larsen, Martin R ^b   Nawrocki, Arkadiusz ^b   Vainer, Ben ^g   Krustrup, Dorrit ^g   Bjørling Poulsen, Marina ^c   Karsdal, Morten A ^a   Leeming, Diana J ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d Nordic Bioscience Beijing   (Denmark)

^e Svenborg Hospital   (Denmark)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ELASTIN; ELM 2 NEOEPITOPE; ELM NEOEPITOPE; GELATINASE B; MACROPHAGE ELASTASE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; EPITOPE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RECEIVER OPERATING CHARACTERISTIC; SMOKING HABIT; ATHEROSCLEROTIC PLAQUE; BLOOD; CHEMISTRY; FEMALE; HEART INFARCTION; MALE; PROCEDURES;

ULMUS;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ELASTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; PROTEOLYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84879259071     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060936     Document Type: Article

References (117)

1. Li H, Yang S, Mu B, Rong Z, Zhang J (2007 a) Molecular phylogenetic diversity of the microbial community associated with a high-temperature petroleum reservoir at an offshore oilfield. FEMS microbiology ecology 60: 74-84.
2. Bastin ES, (1926) The problem of the natural reduction of sulphates. Bull. Am. Associat. Petrol. Geologists 10: 1270-1299.
3. Sen R, (2008) Biotechnology in petroleum recovery: The microbial EOR. Progress in Energy and Combustion Science 34: 714-724.
4. Ren HY, Zhang XJ, Song ZY, Rupert W, Gao GJ, et al. (2011) Comparison of microbial community compositions of injection and production well samples in a long-term water-flooded petroleum reservoir. PLoS ONE 6: e23258.
5. Tang YQ, Li Y, Zhao JY, Chi CQ, Huang LX, et al. (2012) Microbial Communities in Long-Term, Water-Flooded Petroleum Reservoirs with Different in situ Temperatures in the Huabei Oilfield, China. PLoS ONE 7: e33535.
6. Aitken CM, Jones DM, Larter SR, (2004) Anaerobic hydrocarbon biodegradation in deep subsurface oil reservoirs. Nature 431: 291-294.
7. Antipov VA, Levashova VI, (2002) New nitrogen-compounds as sulfate-reducing bacterial growth inhibitors in petroleum production. Petro Chem 6: 475-478.
8. Youssef N, Simpson DR, Duncan KE, McInerney MJ, Folmsbee M, et al. (2007) In-situ biosurfactant production by Bacillus strains injected into a limestone petroleum reservoir. Appl Environ Microbiol 73: 1239-47.
9. Akit RJ, Cooper DG, Neufield RJ, (1989) Effects of oil reservoir conditions on the production of water-insoluble levan by Bacillus licheniformis. Geomicrobiol J 7: 115-65.
10. Fratesi SE (2002) Distribution and morphology of bacteria and their byproducts in microbial enhanced oil recovery operations MS thesis, Mississippi State University.
11. Rueter P, Rabus R, Wilkes H, Aeckersberg F, Rainey FA, et al. (1994) Anaerobic oxidation of hydrocarbons in crude oil by new types of sulphate-reducing bacteria. Nature 372: 455-458.
12. L'Haridon S, Reysenbach AL, Glenat P, Prieur D, Jeanthon C, (1995) Hot subterranean biosphere in a continental oil reservoir. Nature 377: 223-224.
13. Grassia GS, McLean KM, Glenat P, Bauld J, Sheehy AJ, (1996) A systematic survey for thermophilic fermentative bacteria and archaea in high temperature petroleum reservoirs. FEMS Microbiol Ecol 21: 47-58.
14. Nilsen RKC, Torsvik T, (1996b) Methanococcus thermolithotrophicus isolated from North Sea oil field reservoir water. Appl Environ Microbiol 62: 728-731.
15. Davydova-Charakhch'yan IA, Mileeva AN, Mityushina LL, Belyaev SS, (1993) Acetogenic bacteria from oil fields of Tataria and western Siberia. Microbiology 61: 306-315.
16. Greene AD, Patel BKC, Sheehy AJ, (1997) Deferribacter thermophilus gen. nov., sp. nov., a novel thermophilic manganeseand iron-reducing bacterium isolated from a petroleum reservoir. Int J Syst Bacteriol 47: 505-509.
17. Slobodkin AI, Jeanthon C, L'Haridon S, Nazina TN, Miroshnichenko ML, et al. (1999) Dissimilatory reduction of Fe III) by thermophilic bacteria and archaea in deep subsurface petroleum reservoirs of Western Siberia. Curr Microbiol 39: 99-102.
18. Stetter KO, Huber R, Blöchl E, Kurr M, Eden RD, et al. (1993) Hyperthermophilic archaea are thriving in deep North Sea and Alaskan oil reservoirs. Nature 365: 743-745.
19. Eckford RE, Fedorak PM, (2002) Planktonic nitrate-reducing bacteria and sulfate-reducing bacteria in some western Canadian oil field waters. J Ind Microbiol Biot 29: 83-92.
20. Magot M, Ollivier B, Patel BKC, (2000) Microbiology of petroleum reservoirs. Antonie van Leeuwenhoek 77: 103-116.
21. She Y, Zhang F, Xiang T, Liu B, Zhao L, et al. (2005) Microbial diversity in petroleum reservoirs analyzed by PCR-DGGE. Acta Ecologica Sinica 25: 237-242.
22. Li H, Yang SZ, Mu BZ (2007 b) Phylogenetic diversity of the archaeal community in a continental high-temerature, water-flooded petroleum reservoir. Curr Microbiol. 55: 382-388.
23. Yuan S, Xue Y, Gao P, Wang W, Ma Y, et al. (2007) Microbial diversity in shengli petroleum reservoirs analyzed by T-RFLP. Acta microbiologica Sinica 47: 290-294.
24. Margulies M, Michael E, Altman WE, Attiya S, Bader JS, et al. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380.
25. Roesch L, Fulthorpe R, Riva A, Casella G, Hadwin A, et al. (2007) Pyrosequencing enumerates and contrasts soil microbial diversity. ISME J. 1: 283-290.
26. Qian P, Wang Y, Lee O, Lau S, Yang J, et al. (2011) Vertical stratification of microbial communities in the Red Sea revealed by 16S rDNA pyrosequencing. ISME J. 5: 507-518.
27. Kryachko Y, Dong X, Sensen CW, Voordouw G, (2012) Compositions of microbial communities associated with oil and water in a mesothermic oil field. Antonie Van Leeuwenhoek 101: 493-506.
28. Folarin Y, An D, Caffrey S, Soh J, Sensen CW, et al. (2012) Contribution of make-up water to the microbial community in an oilfield from which oil is produced by produced water re-injection. International Biodeterioration & Biodegradation xxx: 1-7.
29. American Public Health Association (2005) Standard methods for the examination of water and wastewater, 21st edn. American Waterworks Association and Water Pollution Control Federation, Baltimore, MD.
30. Porter KG, Feig YS, (1980) The use of DAPI for identifying and counting aquatic microflora. Limnol. Oceanogr 25: 943-948.
31. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, et al. (1990) Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microb 56: 1919-1925.
32. Raskin L, Stromley JM, Rittmann BE, Stahl DA, (1994) Group specific 16S rRNA hybridization probes to describe natural communities of methanogens. Appl Environ Microb 60: 1232-1240.
33. Teira E, Reinthaler T, Pernthaler A, Pernthaler J, Herndl GJ, (2004) Combining catalyzed reporter deposition-fluorescence in situ hybridization and microautoradiography to detect substrate utilization by bacteria and archaea in the deep ocean. Appl. Environ. Microbiol. 70: 4411-4414.
34. Garcia-Armisen T, Papalexandratou Z, Hendryckx H, Camu N, Vrancken G, et al. (2010) Diversity of the total bacterial community associated with Ghanaian and Brazilian cocoa bean fermentation samples as revealed by a 16 S rRNA gene clone Library. Applied Microbiology and Biotechnology 87: 2281-2292.
35. Yuan S, Cohen DB, Ravel J, Abdo Z, Forney LJ, (2012) Evaluation of Methods for the Extraction and Purification of DNA from the Human Microbiome. PLoS ONE 7(3): e33865).
36. Kielty CM, Sherratt MJ, Shuttleworth CA, (2002) Elastic fibres. J Cell Sci 115: 2817-2828.
37. Petersen E, Gineitis A, Wagberg F, Angquist KA, (2001) Serum levels of elastin-derived peptides in patients with ruptured and asymptomatic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 22: 48-52.
38. Jacob MP, Wei SM, Ghuysen-Itard A, Fulop T, Robert L, (1992) [Elastin and arteriosclerosis: determination and characterization of elastin peptides in blood]. C R Seances Soc Biol Fil 186: 342-348.
39. Dillon TJ, Walsh RL, Scicchitano R, Eckert B, Cleary EG, et al. (1992) Plasma elastin-derived peptide levels in normal adults, children, and emphysematous subjects. Physiologic and computed tomographic scan correlates. Am Rev Respir Dis 146: 1143-1148.
40. Schriver EE, Davidson JM, Sutcliffe MC, Swindell BB, Bernard GR, (1992) Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers, and patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 145: 762-766.
41. Wendel DP, Taylor DG, Albertine KH, Keating MT, Li DY, (2000) Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol 23: 320-326.
42. Kielty CM, (2006) Elastic fibres in health and disease. Expert Rev Mol Med 8: 1-23.
43. Turino GM, Lin YY, He J, Cantor JO, Ma S, (2012) Elastin Degradation: An Effective Biomarker in COPD. COPD 9: 435-8.
44. Wohlschlaeger J, Stubbe HD, Schmitz KJ, Kawaguchi N, Takeda A, et al. (2005) Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model. Pathol Res Pract 201: 809-817.
45. Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, et al. (2004) Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109: 1408-1414.
46. Johnson JL, George SJ, Newby AC, Jackson CL, (2005) Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A 102: 15575-15580.
47. Skjot-Arkil H, Barascuk N, Register T, Karsdal MA, (2010) Macrophage-Mediated Proteolytic Remodeling of the Extracellular Matrix in Atherosclerosis Results in Neoepitopes: A Potential New Class of Biochemical Markers. Assay Drug Dev Technol 8: 542-552.
48. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, et al. (2002) The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 11: 569-576.
49. Marciniak SJ, Lomas DA, (2009) What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax 64: 359-364.
50. Lagente V, Le QC, Boichot E, (2009) Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin Ther Targets 13: 287-295.
51. Lemjabbar H, Gosset P, Lechapt-Zalcman E, Franco-Montoya ML, Wallaert B, et al. (1999) Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol 20: 903-913.
52. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, et al. (1998) Peripheral blood levels of matrix metalloproteases-2 and-9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32: 368-372.
53. Zeng B, Prasan A, Fung KC, Solanki V, Bruce D, et al. (2005) Elevated circulating levels of matrix metalloproteinase-9 and-2 in patients with symptomatic coronary artery disease. Intern Med J 35: 331-335.
54. Tanner RM, Lynch AI, Brophy VH, Eckfeldt JH, Davis BR, et al. (2011) Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension. PLoS One 6: e23609.
55. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD, (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004.
56. Yamada S, Wang KY, Tanimoto A, Fan J, Shimajiri S, et al. (2008) Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. Am J Pathol 172: 1419-1429.
57. Lambert JM, Lopez EF, Lindsey ML, (2008) Macrophage roles following myocardial infarction. Int J Cardiol 130: 147-158.
58. Petersen E, Gineitis A, Wagberg F, Angquist KA, (2001) Serum levels of elastin-derived peptides in patients with ruptured and asymptomatic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 22: 48-52.
59. Fritze O, Romero B, Schleicher M, Jacob MP, Oh DY, et al. (2012) Age-related changes in the elastic tissue of the human aorta. J Vasc Res 49: 77-86.
60. Ashworth JL, Murphy G, Rock MJ, Sherratt MJ, Shapiro SD, et al. (1999) Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J 340 (Pt 1): 171-181.
61. Kielty CM, Woolley DE, Whittaker SP, Shuttleworth CA, (1994) Catabolism of intact fibrillin microfibrils by neutrophil elastase, chymotrypsin and trypsin. FEBS Lett 351: 85-89.
62. Petersen E, Gineitis A, Wagberg F, Angquist KA, (2001) Serum levels of elastin-derived peptides in patients with ruptured and asymptomatic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 22: 48-52.
63. Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E, et al. (2010) Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers - are they the cause or the consequence of the disease? Clin Biochem 43: 793-804.
64. Karsdal MA, Delvin E, Christiansen C, (2011) Protein fingerprints - relying on and understanding the information of serological protein measurements. Clin Biochem 44: 1278-1279.
65. Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, et al. (2010) A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem 43: 899-904.
66. Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, et al. (2011) Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-Increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem.
67. Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, et al. (2009) Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers 14: 181-202.
68. Skjot-Arkil H, Schett G, Zhang C, Larsen DV, Wang Y, et al. (2012) Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis. Clin Exp Rheumatol 30: 371-379.
69. Veidal SS, Vassiliadis E, Barascuk N, Zhang C, Segovia-Silvestre T, et al. (2010) Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis. Liver Int 30: 1293-1304.
70. Leeming DJ, Alexandersen P, Karsdal MA, Qvist P, Schaller S, et al. (2006) An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol.
71. Leeming DJ, Larsen DV, Zhang C, Hi Y, Veidal SS, et al. (2010) Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) - assessment of corresponding epitopes. Clin Biochem 43: 1249-1256.
72. Schaller S, Henriksen K, Hoegh-Andersen P, Sondergaard BC, Sumer EU, et al. (2005) In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist? Assay Drug Dev Technol 3: 553-580.
73. Umeda H, Aikawa M, Libby P, (2011) Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases. Biochem Biophys Res Commun 411: 281-286.
74. Kuznetsova T, Herbots L, Lopez B, Jin Y, Richart T, et al. (2009) Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2: 105-112.
75. Vassiliadis E, Barascuk N, Didangelos A, Karsdal MA, (2012) Novel cardiac-specific biomarkers and the cardiovascular continuum. Biomark Insights 7: 45-57.
76. O'Rourke MF, Safar ME, Dzau V, (2010) The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med 15: 461-468.
77. Muehlschlegel JD, Perry TE, Liu KY, Nascimben L, Fox AA, et al. (2009) Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J 30: 1574-1583.
78. Stamatelopoulos KS, Papamichael CM, Zacharoulis A, Papaioannou T, Kollias GE, et al. (2008) Heartscore calculated in individuals younger than 40 years is related to vascular markers of early atherosclerosis. Eur J Cardiovasc Prev Rehabil 15: 619-624.
79. Hoffmann U, Brady TJ, Muller J, (2003) Cardiology patient page. Use of new imaging techniques to screen for coronary artery disease. Circulation 108: e50-e53.
80. Skjot-Arkil H, Clausen RE, Nguyen QH, Wang Y, Zheng Q, et al. (2012) Measurement of MMP-9 and-12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMC Pulm Med 12: 34.
81. Starcher BC, Galione MJ, (1976) Purification and comparison of elastins from different animal species. Anal Biochem 74: 441-447.
82. Partridge SM, Davis HF, Dair GS, (1955) The chemistry of connective tissues. 2. Soluble proteins derived from partial hydrolysis of elastin. Biochem J 61: 11-21.
83. Zhen EY, Brittain IJ, Laska DA, Mitchell PG, Sumer EU, et al. (2008) Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 58: 2420-2431.
84. Thingholm TE, Larsen MR (2009) The use of titanium dioxide micro-columns to selectively isolate phosphopeptides from proteolytic digests. Methods Mol Biol 527: 57-66, xi.
85. Combet C, Blanchet C, Geourjon C, Deleage G, (2000) NPS@: network protein sequence analysis. Trends Biochem Sci. 25: 147-150.
86. Gefter ML, Margulies DH, Scharff MD, (1977) A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet 3: 231-236.
87. Diederichsen AC, Sand NP, Norgaard B, Lambrechtsen J, Jensen JM, et al. (2012) Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study. Eur J Prev Cardiol 19: 558-564.
88. Thygesen K, Alpert JS, White HD, (2007) Universal definition of myocardial infarction. Eur Heart J 28: 2525-2538.
89. Warming L, Hassager C, Christiansen C, (2002) Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 13: 105-112.
90. Mouritzen U, Christgau S, Lehmann HJ, Tanko LB, Christiansen C, (2003) Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis 62: 332-336.
91. Hanley JA, McNeil BJ, (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
92. Barroso B, Abello N, Bischoff R, (2006) Study of human lung elastin degradation by different elastases using high-performance liquid chromatography/mass spectrometry. Anal Biochem 358: 216-224.
93. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, et al. (2006) Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 116: 753-759.
94. Senior RM, Griffin GL, Mecham RP, (1982) Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest 70: 614-618.
95. Ma S, Lieberman S, Turino GM, Lin YY, (2003) The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc Natl Acad Sci U S A 100: 12941-12943.
96. Heinz A, Jung MC, Duca L, Sippl W, Taddese S, et al. (2010) Degradation of tropoelastin by matrix metalloproteinases - cleavage site specificities and release of matrikines. FEBS J 277: 1939-1956.
97. Taddese S, Weiss AS, Jahreis G, Neubert RH, Schmelzer CE, (2009) In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24. Matrix Biol 28: 84-91.
98. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, et al. (1997) Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99: 1534-1545.
99. Gioia M, Fasciglione GF, Monaco S, Iundusi R, Sbardella D, et al. (2010) pH dependence of the enzymatic processing of collagen I by MMP-1 (fibroblast collagenase), MMP-2 (gelatinase A), and MMP-14 ectodomain. J Biol Inorg Chem 15: 1219-1232.
100. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, et al. (1999) Evidence for increased collagenolysis by interstitial collagenases-1 and-3 in vulnerable human atheromatous plaques. Circulation 99: 2503-2509.
101. Billinghurst RC, Ionescu M, Poole AR, (2010) Immunoassays for collagenase-mediated cleavage of type I and II collagens. Methods Mol Biol 622: 349-366.
102. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, et al. (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273: 32347-32352.
103. Benoit M, Thuny F, Le PY, Lepidi H, Bastonero S, et al. (2010) The transcriptional programme of human heart valves reveals the natural history of infective endocarditis. PLoS One 5: e8939.
104. Wohlschlaeger J, Stubbe HD, Schmitz KJ, Kawaguchi N, Takeda A, et al. (2005) Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model. Pathol Res Pract 201: 809-817.
105. Turner NA, Aley PK, Hall KT, Warburton P, Galloway S, et al. (2007) Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and-independent mechanisms. J Mol Cell Cardiol 43: 168-176.
106. Orn S, Manhenke C, Squire IB, Ng L, Anand I, et al. (2007) Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function. J Card Fail 13: 843-849.
107. Johnson JL, George SJ, Newby AC, Jackson CL, (2005) Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci U S A 102: 15575-15580.
108. Madsen SH, Sumer EU, Bay-Jensen AC, Sondergaard BC, Qvist P, et al. (2010) Aggrecanase- and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in time ex vivo. Biomarkers 15: 266-276.
109. Sato Y, Fujiwara H, Takatsu Y (2012) Cardiac troponin and heart failure in the era of high-sensitivity assays. J Cardiol.
110. Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, et al. (2010) Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study. Eur J Clin Invest 40: 288-293.
111. Rosenberg M, Zugck C, Nelles M, Juenger C, Frank D, et al. (2008) Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail 1: 43-49.
112. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF, (2011) Pre- and post-translational regulation of osteopontin in cancer. J Cell Commun Signal 5: 111-122.
113. Rittling SR, Denhardt DT, (1999) Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 7: 103-113.
114. Yoshitake H, Rittling SR, Denhardt DT, Noda M, (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A 96: 8156-8160.
115. Fuernau G, Zaehringer S, Eitel I, de Waha S, Droppa M, et al. (2012) Osteoprotegerin in ST-elevation myocardial infarction: Prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. Int J Cardiol.
116. Venuraju SM, Yerramasu A, Corder R, Lahiri A, (2010) Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol 55: 2049-2061.
117. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA, (2010) Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 137: 1091-1097.